[1]陈 卓,朴红梅.血液生物标志物在肺栓塞诊治及预后判断中的应用[J].医学信息,2022,35(23):181-185.[doi:10.3969/j.issn.1006-1959.2022.23.040]
 CHEN Zhuo,PIAO Hong-mei.Application of Blood Biomarkers in Diagnosis, Treatment and Prognosis of Pulmonary Embolism[J].Journal of Medical Information,2022,35(23):181-185.[doi:10.3969/j.issn.1006-1959.2022.23.040]
点击复制

血液生物标志物在肺栓塞诊治及预后判断中的应用()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年23期
页码:
181-185
栏目:
综述
出版日期:
2022-12-01

文章信息/Info

Title:
Application of Blood Biomarkers in Diagnosis, Treatment and Prognosis of Pulmonary Embolism
文章编号:
1006-1959(2022)23-0181-05
作者:
陈 卓朴红梅
(延边大学附属医院呼吸内科,吉林 延吉 133000)
Author(s):
CHEN ZhuoPIAO Hong-mei
(Department of Respiratory Medicine,Yanbian University Hospital,Yanji 133000,Jilin,China)
关键词:
肺栓塞静脉血栓栓塞生物标志物
Keywords:
Pulmonary embolismVenous thromboembolismBiochemical markers
分类号:
R563.5
DOI:
10.3969/j.issn.1006-1959.2022.23.040
文献标志码:
A
摘要:
肺栓塞(PE)是一种严重威胁健康的肺部疾病,主要继发于深静脉血栓形成,并可导致死亡。及早诊断与治疗对于减少急性肺栓塞患者的死亡率至关重要。许多血清生物标志物能够在常规实验室检查中轻易获取,且能够为诊断、治疗及预后提供依据。已有不少研究表明部分血清生物标志物对肺栓塞的预后有一定的预测作用,故本文就临床上可能有助于判断肺栓塞预后的部分生物标志物进行综述。
Abstract:
Pulmonary embolism (PE) is a serious threat to health of lung disease, mainly secondary to deep vein thrombosis, and can lead to death. Early diagnosis and treatment are essential to reduce mortality in patients with acute pulmonary embolism. Many serum biomarkers can be easily obtained in routine laboratory tests and can provide a basis for diagnosis, treatment and prognosis. Many studies have shown that some serum biomarkers have a certain predictive effect on the prognosis of pulmonary embolism. Therefore, this article reviews some biomarkers that may help to judge the prognosis of pulmonary embolism.

参考文献/References:

[1]Kunutsor SK,Seidu S,Blom AW,et al.Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence[J].Eur J Epidemiol,2017,32(8):657-667.[2]Wu YY,Tan Y,Yan M,et al.Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE[J].Int J Gen Med,2021,27,14:7181-7185.[3]Büyüksirin M,Anar C,Polat G,et al.Can the Level of CRP in Acute Pulmonary Embolism Determine Early Mortality[J].Turk Thorac J,2021,22(1):4-10[4]?魻zcan S,D?觟nmezet E,Inceal O,et al.The Prognostic Value of C-Reactive Protein/Albumin Ratio in Acute Pulmonary Embolism[J].Rev Invest Clin,2022,15,74(2):97-103.[5]Jovanovic L,Subota V,Stavric M,et al.Biomarkers for the prediction of early pulmonary embolism related mortality in spontaneous and provoked thrombotic disease[J].Clin Chim Acta,2019,492:78-83.[6]Branchford BR,Carpenter SL.The Role of Inflammation in Venous Thromboembolism[J].Front Pediatr,2018,6:142.[7]Tan?覦k VO,?覶?覦nar T,Karabag Y,et al.The prognostic value of the serum albumin level for long-term prognosis in patients with acute pulmonary embolism[J].Clin Respir J,2020,14(6):578-585.[8]Omar HR,Mirsaeidi M,Rashad R,et al.Association of serum albumin and severity of pulmonary embolism[J].Medicina (Kaunas),2020,56(1):26.[9]Hoskin S,Chow V,Kritharides L,et al.Incidence and impact of hypoalbuminaemia on outcomes following acute pulmonary embolism[J].Heart Lung Circ,2020,29(2):280-287.[10]Fang J,Xu B.Blood Urea Nitrogen to Serum Albumin Ratio Independently Predicts Mortality in Critically III Patients With Acute Pulmonary Embolism[J].ClinAppl Thromb Hemost,2021,27:10760296211010241.[11]?魻zcan S,D?觟nmez E,Yavuz TS,et al.The Prognostic Value of C-Reactive Protein/Albumin Ratio in Acute Pulmonary Embolism[J].Rev Invest Clin,2022,15,74(2):097-103.[12]Tatlisu MA,Kaya A,Keskin M,et al.The association of blood urea nitrogen levels with mortality in acute pulmonary embolism[J].J Crit Care,2017,39:248-253.[13]G?觟k G,Karadag M,?覶?覦nar T,et al.In-hospital and short-term predictors of mortality in patients with intermediate-high risk pulmonary embolism[J].J Cardiovasc Thorac Res,2020,12(4):321-327.[14]Kim H,Lee K,Choi HA,et al.Elevated blood urea nitrogen/creatinine ratio is associated with venous thromboembolism in patients with acute ischemic stroke[J].J Korean Neurosurg Soc,2017,60(6):620-626.[15]Melchio R,Rinaldi G,Testa E,et al.Red cell distribution width predicts mid-term prognosis in patients hospitalized with acute heart failure: the RDW in acute heart failure (RE-AHF) study[J].Intern Emerg Med,2019,14(2):239-247[16]Zurauskaite G,Meier M,Voegeli A,et al.Biological pathways underlying the association of red cell distribution width and adverse clinical outcome: results of a prospective cohort study[J].PloS ONE,2018,13(1):e0191280.[17]Wang J,Wan Z,Liu Q.Predictive value of red blood cell distribution width in chronic obstructive pulmonary disease patients with pulmonary embolism[J].Anal Cell Pathol (Amst),2020,2020:1935742.[18]Jurin I,Trkulja V,Lucijanic M.Red Cell Distribution Width in Acute Pulmonary Embolism Patients Improves 30-Day Mortality Risk Stratification Based on the Pulmonary Embolism Severity Index[J].Heart Lung Circ,2022,31(6):859-866.[19]Akgedik R,Karamanli H,Kurt AB,et al.Usefulness of admission red blood cell distribution width as a predictor of severity of acute pulmonary embolism[J].Clin Respir J,2018,12(2):786-794.[20]Pehlivanlar KM,Oztuna F,Abul Y,et al.Prognostic value of red cell distribution width and echocardiographic parameters in patients with pulmonary embolism[J].Adv Respir Med,2019,87(2):69-76.[21]Yazici S,Kiris T,Sadik CU,et al.Relation between dynamic change of red cell distribution width and 30-day mortality in patients with acute pulmonary embolism[J].Clin Respir J,2018,12(3):953-960.[22]Marongiu F,Mameli A,Grandone E,et al.Pulmonary thrombosis: a clinical pathological entity distinct from pulmonary embolism?[J].Semin ThrombHemost,2019,45(8):778-783.[23]Liu C,Zhan HL,Huang ZH,et al.Prognostic role of the preoperative neutrophil-to-lymphocyte ratio and albumin for 30-day mortality in patients with postoperative acute pulmonary embolism[J].BMC Pulm Med,2020,20(1):180.[24]Wang Q,Ma J,Jiang Z,et al.Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: A systematic review and meta-analysis[J].Int Angiol,2018,37(1):4-11.[25]Omar M,Tanriverdi O,Cokmert S,et al.Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer[J].Clin Respir J,2018,12(3):922-929.[26]Ertem AG,Yayla C,Acar B,et al.Relation between lymphocyte to monocyte ratio and short-term mortality in patients with acute pulmonary embolism[J].Clin Respir J,2018,12(2):580-586.[27]Kose N,Yildirim T,Akin F,et al.Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism[J].Bosn J Basic Med Sci,2020,20(2):248-253.[28]Ganjali S,Gotto AM Jr,Ruscica M,et al.Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases[J].J Cell Physiol,2018,233(12):9237-9246.[29]Zhang X,Ding R,Li H,et al.An Association between Inflammation and Cerebral Venous Thrombosis: A Retrospective Study[J].J Stroke Cerebrovasc Dis,2021,30(11):106084.[30]Avci A,Biricik S,Avci BS,et al.The new prognostic factor for pulmonary embolism: The ratio of monocyte count to HDL cholesterol[J].Am J Emerg Med,2021,46:212-216.[31]Lin YC,Chen SC,Huang CM,et al.Clinical features and diagnosis of new malignancy in patients with acute pulmonary embolism and without a history of cancer[J].J Chin Med Assoc,2020,83(3):245-250.[32]Lin W,Wu Y,Lu X,et al.Association between mean platelet volume and pulmonary embolism: a systematic review and meta-analysis[J].Aging (Albany NY),2021,13(13):17253-17273.[33]Díaz JM,Boietti BR,Vazquez FJ,et al.Mean platelet volume as a prognostic factor for venous thromboembolic disease[J].Rev Med Chil,2019,147(2):145-152.[34]Farah R,Nseir W,Kagansky D,et al.The role of neutrophil-lymphocyte ratio, and mean platelet volume in detecting patients with acute venous thromboembolism[J].J Clin Lab Anal,2020,34(1):e23010.[35]Araz O,Albez FS,Ucar EY,et al.Predictive Value of Mean Platelet Volume for Pulmonary Embolism Recurrence[J].Lung,2017,195(4):497-502.[36]Li N,Zhang FB,Li BJ,et al.Combination of Preoperative D-Dimer and Platelet Distribution width Predicts Postoperative Deep Venous Thrombosis in Patients with Cervical Carcinoma[J].Asian Pac J Cancer Prev,2019,20(4):1025-1029.[37]Oguz S.Relationship between First Values of Red Cell Distribution Width, Mean Platelet Volume, Platelet Distribution Width, and Hospital Mortality in Acute Deep Venous Thrombosis[J].J Coll Physicians Surg Pak,2021,30(4):379-382.[38]Paku M,Uemura M,Kitakaze M,et al.Impact of the preoperative prognostic nutritional index as a predictor for postoperative complications after resection of locally recurrent rectal cancer[J].BMC Cancer,2021,21(1):435.[39]Iguchi T,Sugimachi K,Mano Y,et al.The preoperative prognostic nutritional index predicts the development of deep venous thrombosis after pancreatic surgery[J].Anticancer Res,2020,40(4):2297-2301.[40]Hay?覦roglu MI,Keskin M,Keskin T,et al.A novel independent survival predictor in pulmonary embolism: prognostic nutritional index[J].Clin Appl ThrombHemost,2018,24(4):633-639.

相似文献/References:

[1]黄亮辉,刘 强,赵艳平,等.复杂性回收下腔静脉滤器病例报道1例[J].医学信息,2019,32(03):189.[doi:10.3969/j.issn.1006-1959.2019.03.065]
[2]周 笳,董丽霞.阿替普酶联合华法林治疗慢阻肺合并肺栓塞的有效性分析[J].医学信息,2019,32(05):146.[doi:10.3969/j.issn.1006-1959.2019.05.046]
 ZHOU Jia,DONG Li-xia.Efficacy Analysis of Alteplase Combined with Warfarin in the Treatment of Chronic Obstructive Pulmonary Disease with Pulmonary Embolism[J].Journal of Medical Information,2019,32(23):146.[doi:10.3969/j.issn.1006-1959.2019.05.046]
[3]祁 闻,赵 红,王龙胜,等.肺栓塞CTPA间接征象诊断价值分析及临床意义[J].医学信息,2019,32(08):88.[doi:10.3969/j.issn.1006-1959.2019.08.026]
 QI Wen,ZHAO Hong,WANG Long-sheng,et al.Diagnostic Value and Clinical Significance of CTPA indirect signs in Pulmonary Embolism[J].Journal of Medical Information,2019,32(23):88.[doi:10.3969/j.issn.1006-1959.2019.08.026]
[4]黄文彬,徐 平,曹灵红.急性肺栓塞流行病学研究[J].医学信息,2019,32(18):104.[doi:10.3969/j.issn.1006-1959.2019.18.034]
 HUANG Wen-bin,XU Ping,CAO Ling-hong.Epidemiological Study of Acute Pulmonary Embolism[J].Journal of Medical Information,2019,32(23):104.[doi:10.3969/j.issn.1006-1959.2019.18.034]
[5]赵树娟,崔 英,张雪晴,等.PEmb-Qol量表中文版在肺栓塞患者 生活质量测评中的价值[J].医学信息,2019,32(14):125.[doi:10.3969/j.issn.1006-1959.2019.14.040]
 ZHAO Shu-juan,CUI Ying,ZHANG Xue-qing,et al.The Value of the Chinese Version of PEmb-Qol in the Assessment of Quality of Life in Patients with Pulmonary Embolism[J].Journal of Medical Information,2019,32(23):125.[doi:10.3969/j.issn.1006-1959.2019.14.040]
[6]杨 州,赵 渝.可转换型下腔静脉滤器的应用[J].医学信息,2020,33(12):47.[doi:10.3969/j.issn.1006-1959.2020.12.015]
 YANG Zhou,ZHAO Yu.Application of Convertible Inferior Vena Cava Filter[J].Journal of Medical Information,2020,33(23):47.[doi:10.3969/j.issn.1006-1959.2020.12.015]
[7]庞永华,陈伟南,许科峰,等.TKA应用氨甲环酸后序贯应用两种新型口服抗凝药预防VTE的疗效对比[J].医学信息,2022,35(09):100.[doi:10.3969/j.issn.1006-1959.2022.09.025]
 PANG Yong-hua,CHEN Wei-nan,XU Ke-feng,et al.Comparison of Efficacy of Sequential Application of Two New Oral Anticoagulants in the Prevention of VTE After Application of Tranexamic Acid in TKA[J].Journal of Medical Information,2022,35(23):100.[doi:10.3969/j.issn.1006-1959.2022.09.025]
[8]李灵玉,邹树芳,刘衍芮,等.脊柱术后早期静脉血栓栓塞危险因素的Meta分析[J].医学信息,2022,35(16):55.[doi:10.3969/j.issn.1006-1959.2022.16.012]
 LI Ling-yu,ZOU Shu-fang,LIU Yan-rui,et al.Meta Analysis of Risk Factors for Early Venous Thromboembolism After Spinal Surgery[J].Journal of Medical Information,2022,35(23):55.[doi:10.3969/j.issn.1006-1959.2022.16.012]

更新日期/Last Update: 1900-01-01